About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, May 22nd, 2013

The QualityStocks
Daily Stock List


Carbon Credits International, Inc. (CARN)

First Penny Picks, PennyStocks24, Information Solutions Group, Top Stock Tips, Xtremepicks, and OurHotStockPicks reported this month on Carbon Credits International, Inc. (CARN), and we are highlighting the Company as "One to Watch" this week here at the QualityStocks Daily Newsletter.

Carbon Credits International, Inc. is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company operates a best-in-class mobile commerce and communication platform, doing business as Text-A-Day. Text-A-Day operates a best-in-class mobile commerce and communications platform specifically designed to serve the needs of the mobile aspect of a business. Carbon Credits International has their corporate headquarters in Phoenix, Arizona. The Company's shares trade on the OTC Pink Current Information.

The Text-A-Day platform makes any campaign or product instantly interactive through the mobile phone across all media channels. Carbon Credits allow their clients to conduct business transactions, accept donations and engage in targeted communication campaigns with their customers/donors by way of mobile devices.

With Text-A-Day mobile giving, commerce, and subscriptions, an organization can engage in bulk messaging and accept one-time or recurring credit card transactions of any amount through mobile phones. An entity can sell products or services via secure credit card transactions on mobile phones.

In addition, they can raise more money any time, and in any place. Furthermore, they can collect customer information, increase sales of merchandise through click-and-buy applications, and have instant communication with their subscribers.

Earlier this month, Carbon Credits International announced that they entered into a Letter of Intent (LOI) to acquire certain assets, including revenue, of Six Sigma Services, Inc. This is in exchange for up to 15,000,000 shares of common stock of Carbon Credits to be issued upon Sigma achieving certain revenue benchmarks up to $1,000,000. Six Sigma Services assists online and mobile businesses globally accept credit card payments by providing a merchant account, payment gateway, recurring billing and credit card storage  

The parties anticipate entering into a definitive agreement no later than May 31, 2013. This is pending final approval by the companies' Board of Directors and mutual satisfaction of legal and financial due diligence.

Today, Carbon Credits International announced that their Board of Directors unanimously approved a name change for the Company to SinglePoint, Inc. The Company indicates that this change will better reflect their business.

We're tracking Carbon Credits International, Inc. (CARN) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Carbon Credits International, Inc. (CARN), closed Wednesday's trading session at $0.007, up 40.00%, on 5,029,698 volume with 71 trades. The average volume for the last 60 days is 2,083,224 and the stock's 52-week low/high is $0.0025/$0.20.

Changfeng Energy, Inc. (CFY.V)

AllPennyStocks reported previously on Changfeng Energy, Inc. (CFY.V), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the TSX Venture Exchange, Changfeng Energy, Inc. is a natural gas service provider with operations throughout the People's Republic of China (PRC). They service industrial, commercial, as well as residential customers. The Company's primary goal is to become one of the principal natural gas service providers in Southern China by 2015. Founded in 1995, Changfeng Energy has their headquarters in Toronto, Ontario.

The Company has three business segments. Two of these segments (Gas Connections and Pipeline Sales) combine to form a gas distribution utility. This is Changfeng Energy's principal operation. The utility delivers natural gas to commercial, industrial and residential customers. Changfeng's third business segment is a Compressed Natural Gas (CNG) retail refueling station. This is in Changsha City, Hunan Province. The Company presently owns and operates one fully operational CNG refueling station with the option to build an additional six more stations in Changsha City.

The Company has developed a considerable natural gas pipeline network and urban gas delivery networks, stations, substations and gas pressure regulating stations in Sanya City and Haitang Bay. Changfeng Energy provides safe and reliable delivery of natural gas to homes and businesses via their network of pipelines.

Last month, Changfeng Energy announced that they filed their audited consolidated financial results for the fiscal year ended December 31, 2012. Revenue for fiscal 2012 was $33.3 million; this represents an increase of $5.1 million (18 percent) from $28.2 million in 2011. Gross margin for 2012 was $15.7 million, representing an increase of $4.0 million, or 34 percent, from $11.7 million in 2011. Net income for 2012 was $2.5 million or $0.038 per basic and diluted share. This is in comparison to $1.4 million or $0.021 per basic and diluted share for the same period the year prior.

Recently, Changfeng Energy announced the appointment of Mr. Yan Zhao as the new Chief Financial Officer (CFO) of the Company. Before joining Changfeng, Mr. Zhao was the Manager, Financial Reporting, of KEYreit from February 2012 to March 2013. KEYreit is a TSX listed real-estate investment trust. Before his employment at KEYreit, Mr. Zhao spent seven years in industry and with accounting firms where he held diverse senior positions. Additionally, the Company announced the appointment of Ms. Ann Siyin Lin as the Vice President, Corporate Development of Changfeng Energy. This is in addition to her position as the Corporate Secretary.

Changfeng Energy, Inc. (CFY.V), closed Wednesday's trading session at $0.32, even for the day. The stock's 52-week low/high is $0.16/$0.38.

Prospect Global Resources, Inc. (PGRX)

Stock Analyzer, Stock Stars, and MonsterStocksPicks reported recently on Prospect Global Resources, Inc. (PGRX), StreetInsider, FeedBlitz, PennyTrader Publisher did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Prospect Global Resources, Inc. engages in the exploration and development of a large, high-quality potash deposit situated in the Holbrook Basin of eastern Arizona. Potassium, nitrogen and phosphate are the three main nutrients essential for plant growth.  Prospect operates approximately 90,000 acres of exclusively state and private leases. The Company previously went by the name Triangle Castings, Inc. They changed their name to Prospect Global Resources, Inc. in February of 2011. The Company lists on the Nasdaq Capital Market.

Prospect plans to develop, build and operate a conventional potash mine and modern production facility. This is because of several strategic and competitive advantages. These include shallowness of the potash deposit, existing infrastructure, and closeness to year round markets.

The Holbrook Salt Basin occurs within the Permian Supai Salt Formation in eastern Arizona. The Supai Salt has undergone division into 5 cycles. The uppermost sequence, cycle 5, contains potash mineralization. The Holbrook Basin has significant potash resources at relatively shallow depths. In addition, year-round warm weather reduces capital and operating costs. Moreover, it is near large year-round potash markets in Arizona, California and Mexico.

North Rim Exploration updated Prospect Global Resources' 43-101 mineral resource report. They calculated total Sylvinite of 780 mm tonnes and 81 mm finished tonnes of K2O, of which Prospect owns a 100 percent operated interest. Prospect anticipates producing 2 mm tonnes per year of finished product.

This month, Prospect Global Resources announced that on May 2, 2013, they received a $5 million subordinated loan that meets a required funding milestone required under the Company's senior debt. Prospect planned to begin a $12 million rights offering in which all shareholders of record as of May 16, 2013 will receive their pro rata share of rights to subscribe for units consisting of a share of common stock and one-half a warrant to purchase a share of common stock.

In addition, the Company's intention is to conduct an underwritten public offering in the next few weeks. The expectation is that proceeds from the rights offering and the public offering will be used to continue to fund Prospect's definitive feasibility study, make mandatory repayments of outstanding indebtedness, and pay the expenses associated with the rights offering and the public offering and for general working capital purposes.

Prospect Global Resources, Inc. (PGRX), closed Wednesday's trading session at $0.2202, up 4.36%, on 274,319 volume with 192 trades. The average volume for the last 60 days is 820,754 and the stock's 52-week low/high is $0.211/$6.49.

BioDrain Medical, Inc. (BIOR)

Today we are highlighting BioDrain Medical, Inc. (BIOR), here at the QualityStocks Daily Newsletter.

Based in Eagan, Minnesota, BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system. This system virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. BioDrain is the producer of the FDA approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste.

The design of STREAMWAY® System is to result in reducing overhead costs to hospitals and surgical centers, improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and streamlining the efficiency of the operating room, making surgeries more profitable. The STREAMWAY® System is eco-friendly and it fully automates the collection, measurement and disposal of surgical fluids.

Pertaining to the STREAMWAY® System, operative fluid is suctioned directly from the surgical field into the system. This system automatically measures and records volume before it disposes of the fluid directly into a facility's existing plumbing system. Cleaning the STREAMWAY® System is user-friendly. One detaches the procedure filter, connects BioDrain Medical's proprietary cleaning solution, and activates the clean cycle on the touch screen.

At the end of April, BioDrain announced that they installed their STREAMWAY® System at the Riva Road Surgical Center in Maryland. The surgical center is part of the SurgCenter Development network, an organization that collaborates with local surgeons to create physician-owned and operated ambulatory surgical centers (ASC). This sale to the Riva Road Surgical Center came soon after a successful installation in New Jersey and additional trials running in hospitals across the U.S. BioDrain anticipates seeking global expansion later in 2013.

Last week, BioDrain Medical reported their results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 were $127,727; this is up more than 450 percent in comparison to $22,635 for the same period in 2012. Gross profit for the first quarter of 2013 was $86,123. This represents almost a 10-fold increase from $8,829 for the same period in 2012. Net loss for the period was ($2.1) million, or ($0.02) per diluted share. This is compared to a net loss of ($713,367), or ($0.02) per diluted share, in the comparable period in 2012.

BioDrain Medical, Inc. (BIOR), closed Wednesday's trading session at $0.1605, down 5.87%, on 91,000 volume with 7 trades. The average volume for the last 60 days is 222,653 and the stock's 52-week low/high is $0.046/$0.2799.

Oryon Technologies, Inc. (ORYN)

InvestorPlace, The Trading Report, Todd Horwitz, The Stock Enthusiast, The Best Newsletters, Stock Research Newsletter, Investment House, Market FN, AnotherWinningTrade, Wealthpire Inc., UltimatePennyStock, Wyatt Investment Research, Uncommon Wisdom, and PennyStocks24 reported recently on Oryon Technologies, Inc. (ORYN), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 1997, Oryon Technologies, Inc. is developing and commercializing a three-dimensional, elastomeric, electroluminescent (EL) technology, patented and trademarked under the name ELastoLite®. The creation of ELastoLite® was to replace conventional EL with a highly malleable, flexible and economical elastomeric EL lamp, which is ultra-thin, elastic, washable, and heat-resistant so that it could be applied directly to fabrics. Oryon Technologies is based in Addison, Texas and the Company lists on the OTC Markets' OTCQB.

Oryon Technologies has only one direct subsidiary, Oryon Technologies, LLC (OTLLC). OTLLC is the parent of two wholly owned companies. These are Oryon Technologies Licensing, LLC (OTLIC) and Oryon Technologies Development, LLC (OTD).

In 2002, Oryon acquired the initial elastomeric electroluminescent lighting technology patents and intellectual property. More than 55 patents issued or pending worldwide protect their technologies. ELastoLite® enables thin, flexible, crushable, water-resistant lighting systems to be incorporated into multiple applications. This includes safety apparel, sporting goods, consumer goods and membrane switches, and others. The Company's ELastoLite® has been featured in apparel products sold by Nike, Lands' End and Marmot Mountain Ltd.
ELastoLite® is a unique next generation electroluminescent (EL) lamp. It is three-dimensional, elastomeric, membranous Polymer Thick Film (PTF). It is printed directly on almost any surface and is a polyurethane ink structure. Oryon Technologies is initially focusing on developing solutions for the textile, apparel (sports and safety), and membrane switches industries. In addition, they are looking to expand into molded specialty products. This includes applications for the defense, automotive and point-of-sale (POS) sectors.  

Oryon Technologies will look for industry partners to either co-develop or license ELastoLite® technology in promising new high technology fields that require extended developmental periods. These specific fields include biometric fingerprint sensors in which Oryon holds two promising patents, high-speed roll-to-roll printing that will allow the Company to offer cost effective solutions for floor lighting, greeting cards, printed flexible batteries and solar cells. The Company has a new digital printing process. They now print custom digital quality images with lower minimums, higher resolution and shorter lead times.

Oryon Technologies, Inc. (ORYN), closed Wednesday's trading session at $0.18, up 12.50%, on 320,320 volume with 47 trades. The average volume for the last 60 days is 207,363 and the stock's 52-week low/high is $0.13/$1.11.

Perseus Mining Ltd. (PRU.TO)

Today we are highlighting Perseus Mining Ltd. (PRU.TO), here at the QualityStocks Daily Newsletter.

Listed on the Toronto Stock Exchange, Perseus Mining Ltd. engages in the exploration, evaluation, development, and production of gold properties in West Africa. They are concentrating on under-explored gold belts in this region. The Company achieved their goal to become a producer during 2011. They commenced commercial production on January 1, 2012. Incorporated in 2003, Perseus Mining has their corporate headquarters in Subiaco, Western Australia.

The Company's lead project is the Edikan Gold Mine (EGM) in Ghana. EGM consists of a group of large gold deposits situated in the Ashanti gold belt. Perseus has 650km² of tenements centered on the Ashanti Gold Belt approximately 25km-65km from the 60-million-ounce Obuasi gold deposit. This includes two mining leases that are the focus of initial production for the Edikan Gold Mine (EGM).

Current Reserves at EGM are 3.4Moz with additional Measured and Indicated resources totaling 5.4Moz and Inferred resources at 1.71Moz. The Bokitsi deposit (part of EGM) has Indicated resources of 212,000oz and Inferred resources containing 89,000oz. The Measured and Indicated resources at the Esuajah North deposit at EGM are 920,000oz.

Perseus Mining also has their Grumesa Project. Located east of EGM, this project has 0.5Moz of Measured & Indicated Resources and 0.25Moz of Inferred Resources. Additionally, the Company's Sissingue Gold Project in Côte d'Ivoire is an underexplored project. It has a current open-ended gold resource, containing 0.66Moz in Reserves with 0.925Moz of Measured and Indicated resources and 0.3Moz of Inferred resources. Perseus is targeting production at the Sissingue Gold Project by 2014.

Moreover, Perseus Mining retains a 21 per cent stake in Manas Resources Ltd. They spun Manas off in 2008 as a focused Kyrgyz Republic gold explorer and developer. In addition, Perseus has a 23 per cent (29 per cent fully diluted) stake and a strategic alliance with Burey Gold Ltd. Burey Gold is an ASX-listed exploration company with a focus in Guinea, West Africa.

Perseus Mining Ltd. (PRU.TO), closed Wednesday's trading session at $1.06, down 7.83%, on 1,632,867 volume. The stock's 52-week low/high is $1.03/$3.07.

Mobivity Holdings Corp. (MFON)

SmallCapVoice, SmallCap Network, and FeedBlitz reported earlier on Mobivity Holdings Corp. (MFON), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Mobivity Holdings Corp. is an award-winning provider of patented mobile marketing technologies. The Company is the inventor of C4. This is an innovative enterprise-grade platform; it enables brands to engage mobile consumers across multiple channels. Mobivity also offers a unique HD graphical system via their Display Technology. This allows fans to interact with their mobile phones and high definition video boards and screens in real time. Mobivity Holdings is based in Chandler, Arizona.

The Company's clients include CNN, Disney, the NFL, Sony Pictures, AT&T, USTA, Chick-fil-A, the Golf Channel, NBC Universal, a number of pro sports teams, and many others. Mobivity's C4 solution facilitates short messaging service, multi-media messaging, and interactive voice response interactions through a set of graphical user interfaces, and reporting and analytics capabilities. C4 is a cloud-based solution. It provides extensive mobile communications and extensive CRM features to clients. C4 is integrated with multiple tier-one PSTN/IP carriers and micropayment processing facilities and with carrier premium SMS billing systems.

Mobivity Holdings, between 2011 and 2012, increased their reach from just over 1,000 businesses nationwide to providing almost 6,000 locations with their portfolio of mobile marketing services. Launched in 2006, the Company provides clients from small to medium sized businesses to national brands with simple and affordable access to the same platform that has been used by large corporations.

Today, Mobivity Holdings announced that they appointed Mr. Michael K. Bynum as President and Director. In addition, they appointed Mr. Tom Tolbert, former CEO of Front Door Insights (FDI), as Executive Vice President and Chief Sales Officer.

As President and Director, Mr. Bynum will be responsible for all revenue generating operations of Mobivity Holdings. This includes key talent acquisition and strategic relationships. Mr. Tolbert will lead the Company's next phase of sales expansion. This includes plans to scale outside sales operations, and the deployment of direct sales resources across the nation.

Mobivity Holdings Corp. (MFON), closed Wednesday's trading session at $0.34, up 99.88%, on 379,374 volume with 72 trades. The average volume for the last 60 days is 16,638 and the stock's 52-week low/high is $0.1401/$0.84.

Verde Media Group, Inc. (VMGI)

OTCReporter, Stockpalooza, Momentum Traders, Wise Alerts, BullRally, Stock Rich, HotOTC, Penny Invest, StockEgg, CoolPennyStocks, and The Momentum Traders Network reported previously on Verde Media Group, Inc. (VMGI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Los Angeles, California, Verde Media Group, Inc. operates a managed media financing company with production, distribution, and development functions. The Company develops projects in film, television, as well as corporate media. In addition, Verde Media operates Beyondrace.com, which focuses on artists, music, film, fashion, and art in different forms.

Verde's investment objective is to achieve total return for shareholders through investment in a diverse portfolio of films and television properties targeted at an audience across different genres, and distributed broadly via all mediums. Verde Media Group lists on the OTC Pink Current Information.

Concerning Film, Verde Media believes the vital growth drivers in the film market are the expansion in audience and the digital mediums that are used to deliver content. Pertaining to Television, the Company retains control and ownership of all of the rights in their programming beyond the first-run rights granted to the broadcaster.

Additionally, Verde Media has adopted a 'value' pricing model. With this model, they agree on a 'fair-value' price for a program or series with a broadcaster. This gives Verde greater control over how much profit it can take from each production.

Today, Verde Media Group announced that they formed an Agency division within their Company to produce and distribute all Public Relations (PR), Marketing and business related services for their clients. They signed an agreement with Vermont Peanut Butter Company, Inc. This is to facilitate strategic growth and increased brand recognition on the cusp of major new product development and related cross-promotional campaigns and outreach that the specialty food manufacture is undertaking. Vermont Peanut Butter is a premium nut butter brand.

Mr. William Veve, President of Verde Media Group, stated, "The Agency division of Verde serves as an important revenue generator that allows us to work with our clients on many levels. Vermont Peanut Butter Company is an important addition."

Verde Media Group, Inc. (VMGI), closed Wednesday's trading session at $0.02, up 11.11%, on 212,500 volume with 3 trades. The average volume for the last 60 days is 69,380 and the stock's 52-week low/high is $0.0005/$0.06.


The QualityStocks
Company Corner


Solar Wind Energy Tower, Inc. (SWET)

The QualityStocks Daily Newsletter would like to spotlight Solar Wind Energy Tower, Inc. (SWET). Today, Solar Wind Energy Tower, Inc. closed trading at $0.021, off by 8.70%, on 355,868 volume with 16 trades. The stock’s average daily volume over the past 60 days is 618,215, and its 52-week low/high is $0.01/$0.08.

Solar Wind Energy Tower, Inc. was pleased to report today that they have been allowed a key patent covering their revolutionary Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, as the USPTO issues Patent Application Number 13/098,476, titled "Atmospheric Energy Extraction Devices and Methods." A patent will soon be issued to cover this amazing system, which uses water sprayed across the top of a cylindrical tower to generate downdraft and external capture vanes to maximize the effect, encompassing the overall basic architecture.

Solar Wind Energy Tower, Inc. (SWET) is focused on commercializing a number of proven, validated technologies and construction systems into a single large Solar Wind Downdraft Tower structure that produces abundant, inexpensive electricity. The company's core objective is to become a leading provider of clean, efficient energy at a reasonable cost, while continuing to generate innovative technological solutions for tomorrow's electrical power needs.

The company's cutting-edge energy solution generates clean energy by harnessing the natural power of a downdraft created within the confines of a Solar Wind Downdraft Tower structure. Using benevolent, non-toxic natural elements, the solar/wind hybrid technology is capable of being operated with virtually no carbon footprint, fuel consumption, or waste production. To view a demonstration of the tower, visit http://dtg.fm/4Gp7.

The business plan employed by Solar Wind Energy includes partnering with various entities, such as utilities, sovereign nations, and independent power sources, to bring this solution to the market as rapidly as possible. The company's role would consist of facilitating the Tower's development with its expertise and intellectual property. Revenue streams include development fees, licensing fees, and royalties on power sales from each project and/or ownership interests.

Solar Wind Energy has assembled a team of experienced business professionals, as well as engineering and scientific consultants, with the proven ability to bring new ideas to market. The company has also filed and been issued patents that protect its revolutionary technology and leading position in the continual global pursuit to meet rising demand for energy. Disclaimer

Solar Wind Energy Tower, Inc. Company Blog

Solar Wind Energy Tower, Inc. News:

Solar Wind Energy Tower, Inc. Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"

Solar Wind Energy Tower, Inc. Partners with Commonwealth Dynamics, Inc.

Solar Wind Energy Tower, Inc. Letter to Shareholders of Record

Rafarma Pharmaceuticals, Inc. (RAFA)

The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.11, up 8.91%, on 16,212 volume with 4 trades. The stock’s average daily volume over the past 60 days is 15,517, and its 52-week low/high is $0.0501/$0.98.

Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.

Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.

Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.

Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer

Rafarma Pharmaceuticals, Inc. Company Blog

Rafarma Pharmaceuticals, Inc. News:

Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services

Rafarma Pharmaceuticals Registers CEFTRIAXONE Under International Label

Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products

Cardium Therapeutics, Inc. (CXM)

The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.095, up 4.40%, on 213,143 volume with 128 trades. The stock’s average daily volume over the past 60 days is 521,744, and its 52-week low/high is $0.0618/$0.28.

Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.

The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.

Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.

Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer

Cardium Therapeutics, Inc. Company Blog

Cardium Therapeutics, Inc. News:

Cardium Announces Generx Publication In Molecular Therapy

Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting

Cardium Receives ISO Certification for Excellagen

DoMark Internatioxnal, Inc. (DOMK)

The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.078, up 1.35%, on 249,712 volume with 28 trades. The stock’s average daily volume over the past 60 days is 149,015, and its 52-week low/high is $0.0322/$3.63.

DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.

Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.

Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.

The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer

DoMark International, Inc. Blog

DoMark International, Inc. News:

DoMark International Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares

DoMark Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products

DoMark International Announces the Signing of an M.O.U. to Purchase Game Changing New Samsung and Apple Accessory Product Developer Zaktek Ltd.

Solar Wind Energy Tower, Inc. (SWET) Receives Notice of Patent Allowance Covering Alternative Energy Technology

Solar Wind Energy Tower, the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, today announced the allowance of Patent Application Number 13/098,476, titled “Atmospheric Energy Extraction Devices and Methods”, by the United States Patent and Trademark Office.

The patent covers a structure for producing electricity, specifically a tall tower capable of adding moisture at the top of the structure to hot-dry air so as to generate a downdraft of wind within the interior of the Tower, vanes coupled to the exterior of the Tower that at least partially define a plurality of elongated pockets at the exterior of the Tower, flaps located within the pockets configured to redirect incident wind downwards, and at least a first wind tunnel configured to receive the redirected wind so as to convert such wind to electricity.

Ronald W. Pickett, President, Chief Executive Officer of SWET, stated, “We are pleased to have received notice that our patent application for the Tower structure design has been allowed, and that a patent will be issued shortly. The patent application incorporates the entire core Tower structure, including the injection of moisture as a catalyst to generate the downdraft wind, and the additional exterior dual wind capture vanes. In the future, as we expand our geographic footprint, the dual wind technology will provide us with the ability to construct our power plant in locations with potentially more variable weather conditions, since we can now incorporate the power created by the ambient wind captured along the outer surface of the Tower structure with the power generated internally. This external wind capture boosts the overall power output.”

“This patent allowance, along with our previously issued patent titled ‘Efficient Energy Conversion Devices and Methods’, encompasses our overall basic system architecture,” added Pickett. “We intend to continue to protect our technology as we develop enhancements to it. Our business plan has always been to efficiently extract the maximum energy generated by the captured wind, with the least loss of power while compensating for the normal differentials in atmospheric conditions.”

For more information, visit www.solarwindenergytower.com

ISC8 Inc. (ISCI) Recruits Industry Veterans to Advance Its Expansion of Global Cybersecurity

Provider of intelligent cybersecurity solutions, ISC8, has named three new additions to its team. Scott Millis will sign on as Chief Security Strategy Officer, Kelly Anderson as Vice President of Sales for North America, and finally Gev Pestonji will sit as Vice President of Sales for Asia Pacific.

Previously the Chief IT Strategy Officer at McAfee, Scott Millis brings his expertise of all aspects of IT. His experience in cybersecurity includes application development, computers, governance, and data centers. His experience easily translates across diverse sectors that include manufacturing and distribution.

Mills states, “Having spent considerable time analyzing and vetting ISC8′s technology with industry veterans and CSOs, the feedback was undisputable; the company’s products are 100% geared to address the latest cybersecurity threats facing today’s enterprises.” Mills continues, “The company has well over a dozen trials lined up over the course of the year; the names of the companies involved would be of envy to anyone in the cybersecurity space. ISC8 is a company that I can help grow to be a marquee name in the industry.”

Kelly Anderson, whose resume includes heavyweight Equifax, brings a strong technology background centered on the use of Big Data analytics for telco, social networking, paid TV, and mobile apps. Anderson has twenty years of industry insight and expertise for developing and executing sales and marketing strategies.

“ISC8′s value proposition is clear, compelling, and timely given the resurgence of sophisticated malware and Advanced Persistent Threats attacking large enterprise and service provider networks,” Anderson commented. “In two weeks of account engagements, the feedback has been consistent — ‘When can we have a product to trial?’ Not often does one come into a company and have the ability to talk to Fortune 50 corporations and receive this type of resounding feedback. The portfolio is a perfect match to current and emerging market needs.”

Also joining ISC8 as the Vice President of Sales is Gev Pestonji, who will oversee and manage all anticipated growth in the Asia Pacific region. With over twenty years in sales, Pestonji’s experience includes technology innovators such as Cisco, Nortel, and Siemens.

“ISC8 has built up a strong pipeline of opportunities globally,” commented Pestonji. “I am encouraged about the prospects that ISC8 is working to close over the coming months and look forward to contributing to the company’s global growth.”

Bill Joll, president and CEO of ISC8 stated, “The addition of these key executives signals our commitment to growth in cybersecurity technologies and markets. Their combined experience increases our in-depth understanding of cybersecurity technology platforms and experience across global markets that will provide a strategic advantage in our expansion efforts globally for all three ISC8 cybersecurity products: Cyber adAPT™, a signature-less Advanced Persistent Threat (APT) and malware detection solution; Cyber NetFalcon®, for Big Data security analytics; and Cyber NetControl™, providing content control for service providers and enterprises.” Concluding Joll states, “I am pleased to have found such exceptional talent that will help ISC8 deliver on the significant pipeline of opportunities that has been built up across all three products.”

ISC8 is currently engaged in the development and sale of intelligent cybersecurity solutions for both commercial and government use worldwide.

To learn more visit www.isc8.com

3Pea International, Inc. (TPNL) Launches New PaySignŽ Payments Platform

3Pea International, a payments solution company focused on prepaid debit card processing and program management, announced that the company has launched its new payments processing platform, PaySign®.

Due to the rapidly changing face of payment technologies and customer demands, 3Pea built the PaySign® platform on modern cross-platform architecture and designed it to be highly flexible, scalable, and customizable. PaySign® will allow the company to significantly expand its operational capabilities, allowing 3Pea to enter new markets within the payments processing space.

The payment processing platform was designed to easily incorporate new payment technologies and applications as they evolve, allowing 3Pea to remain at the forefront of payment innovation. PaySign® also provides flexibility and efficiencies that will allow the company to significantly reduce the time and cost related to card program development and customization, resulting in increasing operating margins. The PaySign® platform was created with the ability to facilitate EMV (EuroPay, MasterCard, and Visa) smart card payment system (Chip and PIN) payments on a global basis.

PaySign®, in development for several years, meets PCI-DSS 2.0 compliance standards and was part of the company’s most recent successful PCI-DSS audit. The audit, underscoring 3Pea’s continuing commitment to maintaining the highest level of data security standards and compliance, certified 3Pea as a Level 1 Service Provider (Issuer), Gateway/Switch, Prepaid Services, and Issuer Processing Provider.

Additionally, PaySign® Platform will be integral in the development, launch, and support of the PaySign® brand of prepaid debit cards, 3Pea’s line of prepaid cards targeting the General Spend, Corporate, Government, and International markets.

Integrating rapid rendering and modern web technologies that has solid cross-browser support, the user interface for the platform’s Card Management System (CMS) will simplify card program administration. The platform also boasts Interactive Voice Response (IVR) and two-way SMS messaging, which supports cardholder inquiries and card activation.

“We are extremely excited about the launch of our PaySign® platform and the growth opportunities it affords 3Pea as both a payments processor and prepaid debit card manager. We are confident in our ability to successfully enter key market verticals and broaden our prepaid debit card offerings,” stated Mark Newcomer, President and CEO of 3Pea International. “We feel that the successful development and launch of the PaySign® platform is a defining moment for 3Pea.”

For more information on 3Pea International, visit www.3pea.com

iBio, Inc. (IBIO) Produces a Vaccine Candidate for the Newly Emerged H7N9 Virus

iBio develops and offers product applications of its proprietary iBioLaunch and iBioModulator platforms. In addition, the company develops select vaccine candidates that have been derived from its iBioLaunch platform. Its technology utilizes transient gene expression in unmodified green plants for the development and production of biologics.

The company announced today the production of a vaccine candidate for the recently emerged H7N9 influenza virus (first appeared in China) by an independent third-party laboratory using its BioLaunch platform. This accomplishment took only 21 days as measured from the initial antigen sequence information to purification of recombinant protein.

iBio’s BioLaunch platform eliminates the need to culture cells under sterile conditions, removes uncertainty about yield consistency for large production volumes, and, subject to regulatory approval, can possibly deliver vaccine doses for emergency use against a pandemic or bio-terrorism threat. The platform has been used successfully before to produce vaccine-quality antigens associated with a range of influenza strains including H7N7, H5N1, H3N2, H1N1, and a variety of influenza B strains.

The company’s iBioLaunch platform is a step ahead of current conventional approaches. It eliminates the months involved in the development and production of regular vaccines for viruses. Patient care now often involves only isolation of patients and supportive care. For further information about iBio and its technologies, please visit www.ibioinc.com.


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Real Pennies


Darth Trader


Jason Bond

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251